7:15 – 7:30 am Physicians Breakfast meeting check in and Continental Breakfast
7:30 – 8:30 am Guest Speaker: Dr. John G Hanly
Professor of Medicine, Div. of Rheumatology, Dept. of Medicine and Pathology, Dalhousie University and Capital Health, Halifax, Nova Scotia
9:00 – 9:05 am Welcome and Opening Remarks
Josie Bradley, Lupus Society President
9:05 – 9:50 am Belimumab (Benlysta) - The New Kid On The Block, And Other Upcoming Drugs
Dr. Jennifer Reynolds, Lupus Clinic Director, Clinical Instructor
Div. of Rheumatology, Faculty of Medicine, University of British Columbia
9:50 – 10:00 am 10 min break
10:00 – 10:55 am Keynote Address: CNS Lupus – A Riddle, Wrapped In A Mystery, Inside An Enigma?
Dr. John G Hanly
Professor of Medicine, Div. of Rheumatology, Dept. of Medicine and Pathology, Dalhousie University and Capital Health, Halifax, Nova Scotia
10:55 – 11:10 am 15 min break
11:10 – 11:55 am The Healing Relationship
Dr. Marjorie Docherty, Clinical Professor, Department of Family Practice at UBC, President of the college of Physicians and Surgeons BC
11:55 – 12:10 pm pick up boxed lunch and return to conference room for Luncheon keynote address
12:15 – 12:50 pm Luncheon Keynote Address: Osteoporosis and Lupus
Dr. Simon Huang, Clinical Associate Professor
Div. of Rheumatology, Faculty of Medicine, University of British Columbia
12:50 – 1:00 pm 10 min break
1:00 – 1:30 pm The Disease Burden of SLE in BC – How Many and How Much?
Dr. Antonio Aviña, BC Lupus Society Scholar
Research Scientist - Arthritis Research Centre, Assistant Professor, Faculty of Medicine, University of British Columbia
1:30 – 3:00 pm Q & A Expert Panel
moderated by Dr. Stephanie Ensworth - Clinical Associate Professor
Div. of Rheumatology, Faculty of Medicine, University of British Columbia
Dr. John G Hanly
A professor in the Division of Rheumatology at Dalhousie Medical School, Dr. Hanly has been studying the impact of lupus on the nervous system for more than 20 years. He is leading the neuropsychiatric (NP) component of an international lupus probe involving 27 centres in 11 countries. Since 2002, the Canadian Institutes of Health Research-funded study has enrolled approximately 1,400 newly diagnosed lupus patients and will follow some for as long as 10 years.
In addition to numerous local research projects, Dr. Hanly contributes to other aspects of the international study, including investigations of cardiovascular disease and cancer in lupus. In a separate study, he is collaborating with Canadian lupus researchers to find the genetic and environmental factors that may trigger the disease.
Dr. Hanly obtained his MD degree from the National University of Ireland in 1978 and pursued training in General Internal Medicine and clinical Rheumatology in Ireland prior to immigrating to Canada in 1984. Clinical Fellowships in Rheumatology and Immunology were pursued at the University of Toronto and McMaster University before joining the Faculty of Medicine at Dalhousie University in 1987.
In addition to clinical care and teaching of general Rheumatology, specific research interests include study of pathogenic mechanisms, prognosis and clinical trials in patients with systemic lupus erythematosus and rheumatoid arthritis. Dr. Hanly is the Director of Research and the Director of Continuing Medical Education for the Division of Rheumatology at Dalhousie University.